Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Search Seller Projects – Asia, Healthcare
Asia: Japan
Japanese hospital specialized in cancer treatment seeks investment.
The Japanese hospital is specialized in integrated and advanced treatment of cancer, comprising examination, prevention, and treatment. It has a close cooperative relationship with various advanced research institutions and medical institutions. It has been continuously studying projects such as advanced treatment of cancer, ultra-early detection, and recurrence prevention for a long time. The company now seeks investment.
Asia: South Korea
Medical company located in the Republic of Korea seeks investment
South Korean medical device production and sales company was founded in 2001 and now has 13 employees. Many of the company's products have independent intellectual property rights in China, Japan, South Korea, Russia, the United States, Australia, Europe and other parts of the world. Its excreta collection equipment launched by the company helps to maintain personal hygiene and effectively reduce and prevent the occurrence of bedsore. The product is composed of a portable host and a disposable collection part. It has the following advantages: excellent design and advanced technology (prevent secondary bacterial infection and pollution, easy to handle waste and observe bloody excreta, environment-friendly, less waste, less cost, easy to use, excellent adhesion). The simple cleaning bag products have passed the test. The company is now looking for investment.
Asia: Japan
Japanese pelvic correction company seeks 100% acquisition.
Japanese company was founded in the 2000s, located in Tokyo. It is mainly engaged in the operation of pelvic correction and yoga training services. Its main customers are high-income individuals aged 30 to 40. The company has 350 stores (including franchisees) worldwide, of which 86% are in Japan. The company's revenue in 2019 was 11.5 billion JPY and its EBITDA was 1.3 billion JPY. At present, the company wants to sell its business, and the acquisition price will not be less than 15 billion JPY.
Asia: Hong Kong
Medical and surgical robot company in Hong Kong seek $30 million for financing
The company is an international medical and surgical R&D robot start-up in Hong Kong, which is led by a strong management team, including 30 year-experienced personnel and other professionals in this field. The market scale of this field is expected to reach US $20 billion and a compound annual growth rate of more than 10% though 2020. Its product has many intellectual property rights, including a magnetic anchor robot system, robot manipulator, etc. The company is now focusing on the development of two revolutionary non-invasive robot systems and seeking $30 million in financing. The first is a disposable soft robot colonoscopy system for colorectal cancer diagnosis which has completed the animal clinical trials and human clinical trials are planned to be conducted in 2020 S2 and are expected to be put into commercial production in 2021. Another is a surgical robot system for colorectal, urological, and gynecological surgery. This robot system is the first in the market to provide forward and reverse surgery, it expands the application field of robot surgery to most abdominal and pelvic surgery processes. The product is now in the preparation stage of clinical trial and is expected to be put into commercial production before 2023.
Asia: Japan
Japanese nursing Robot company seeks investment.
Japanese-based nursing robot company has an excretion treatment device for a wide range of patients (elderly, disabled, recovery, etc.). The device is simple to use and designed with a small size. A high automation level makes the monitoring system more reliable.
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact Us